| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adopting orphaned drugs: developing multidrug regimens using generic drugs
|
Turner, Timothy J.
|
|
2011
|
8 |
3-4 |
p. 117-121
5 p.
|
artikel
|
| 2 |
Cheminformatic/bioinformatic analysis of large corporate databases: Application to drug repurposing
|
Loging, William
|
|
2011
|
8 |
3-4 |
p. 109-116
8 p.
|
artikel
|
| 3 |
Contents
|
|
|
2011
|
8 |
3-4 |
p. i-
1 p.
|
artikel
|
| 4 |
Drug repurposing
|
Lipinski, Christopher A.
|
|
2011
|
8 |
3-4 |
p. 57-59
3 p.
|
artikel
|
| 5 |
Drug repurposing from an academic perspective
|
Oprea, Tudor I.
|
|
2011
|
8 |
3-4 |
p. 61-69
9 p.
|
artikel
|
| 6 |
Drug repurposing through nonhypothesis driven phenotypic screening
|
Reaume, Andrew G.
|
|
2011
|
8 |
3-4 |
p. 85-88
4 p.
|
artikel
|
| 7 |
Formulation technology to repurpose drugs for inhalation delivery
|
Cipolla, David C.
|
|
2011
|
8 |
3-4 |
p. 123-130
8 p.
|
artikel
|
| 8 |
Intellectual property and other legal aspects of drug repurposing
|
Witkowski, Timothy X.
|
|
2011
|
8 |
3-4 |
p. 139-143
5 p.
|
artikel
|
| 9 |
Literature analysis for systematic drug repurposing: a case study from Biovista
|
Lekka, Eftychia
|
|
2011
|
8 |
3-4 |
p. 103-108
6 p.
|
artikel
|
| 10 |
Orphan/rare drug discovery through drug repositioning
|
Muthyala, Ramaiah
|
|
2011
|
8 |
3-4 |
p. 71-76
6 p.
|
artikel
|
| 11 |
Repositioned drugs: integrating intellectual property and regulatory strategies
|
Smith, Richard B.
|
|
2011
|
8 |
3-4 |
p. 131-137
7 p.
|
artikel
|
| 12 |
Repositioning drugs to enhance a product's lifecycle
|
Phelps, Ken
|
|
2011
|
8 |
3-4 |
p. 97-101
5 p.
|
artikel
|
| 13 |
The CTSA Pharmaceutical Assets Portal – a public–private partnership model for drug repositioning
|
Marusina, Kate
|
|
2011
|
8 |
3-4 |
p. 77-83
7 p.
|
artikel
|
| 14 |
theraTRACE®: a mechanism unbiased in vivo platform for phenotypic screening and drug repositioning
|
Saporito, Michael S.
|
|
2011
|
8 |
3-4 |
p. 89-95
7 p.
|
artikel
|
Tijdschrift beschrijving